Document:

Form of Registration Rights Agreement

 Exhibit 10.35 
 REGISTRATION RIGHTS AGREEMENT 
 This Registration Rights Agreement (this
“Agreement”) is made and entered into as of June 5, 2008, among GeoResources, Inc., a Colorado corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, including its successors
and assigns, a “Purchaser,” and collectively, the “Purchasers”). 
 R E C I T A L S 
 WHEREAS, the Company proposes to sell to the Purchasers an aggregate of 1,533,334 shares of the Company’s Common Stock, par value $0.01 per share
(the “Common Stock”) and (ii) warrants to purchase an aggregate of 613,336 shares of Common Stock in the form attached hereto as Exhibit A (the “Warrants”), pursuant to that certain Purchase Agreement
(the “Purchase Agreement”) dated as of even date herewith by and among the Company and the Purchasers; and 
 WHEREAS, the
Company wishes to enter into this Registration Rights Agreement with the Purchasers, and confer upon the Purchasers the benefits provided hereunder, as an inducement to the Purchasers to enter into the Purchase Agreement and consummate the
transactions thereunder. 
 A G R E E M E N T 
 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and the
Purchasers agree as follows: 
 1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the
Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: 
 “Advice” shall have the meaning set forth in Section 7(c). 
 “Allowable Grace
Period” shall have the meaning set forth in Section 3(j). 
 “Effective Date” means the date that the
Registration Statement is declared effective by the Commission. 
 “Effectiveness Deadline” means, with respect to the
initial Registration Statement required hereunder, (i) in the event that the Registration Statement is not subject to a review by the Commission, the earlier of (x) the 5th Business Day following the date on which the Company is notified
by the Commission that the Registration Statement will not be reviewed or is no longer subject to further review and comments, and (y) the date that is 60 calendar days after the Filing Deadline, or (ii) in the event that the Registration
Statement is subject to a review by the Commission, the date that is 120 calendar days after the Closing Date. 
 “Effectiveness
Failure” shall have the meaning set forth in Section 2(b). 

 “Effectiveness Period” means with respect to any Registrable Securities under any
Registration Statement, the period commencing with the Effective Date of the Registration Statement and ending upon the disposition of all Registrable Securities under such Registration Statement. 
 “Filing Date” means, with respect to the initial Registration Statement required hereunder, the date the Registration Statement is filed
with the Commission. 
 “Filing Deadline” means, with respect to the initial Registration Statement required hereunder, 30
calendar days after the Closing Date. 
 “Filing Failure” shall have the meaning set forth in Section 2(b). 

“Grace Period” shall have the meaning set forth in Section 3(j). 
 “Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 “Indemnified Party” shall have the meaning set forth in Section 5(c). 
 “Indemnifying Party” shall have the meaning set forth in Section 5(c). 
 “Losses” shall have the meaning set forth in Section 5(a). 
 “Plan of Distribution” shall have the meaning set forth in Section 2(a). 
 “Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any
information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or
deemed to be incorporated by reference in such Prospectus. 
 “Registrable Securities” means all of (i) the Shares,
(ii) the shares of Common Stock issuable upon the exercise of the Warrants and (iii) any shares of Common Stock issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event of the Company
affecting the Shares or the shares of Common Stock issuable upon the exercise of the Warrants; provided, however, a security shall no longer be a Registrable Security once it has been sold pursuant to Rule 144 under the Securities Act, or may be
sold (x) without restriction or limitation pursuant to Rule 144 and without the requirement to be in compliance with Rule 144(c)(1) (or any successor thereto) promulgated under the 1933 Act or (y) pursuant to a Registration Statement.

 “Registration Delay Payments” shall have the meaning set forth in Section 2(b). 
  

 2 

 “Registration Statement” means the registration statements required to be filed
hereunder, including (in each case) the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference or deemed to
be incorporated by reference in such registration statement. 
 “Rule 415” means Rule 415 promulgated by the Commission
pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. 
 “Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule. 
 “Selling Shareholder Questionnaire” shall have the meaning set forth in Section 3(a). 
 2. Shelf
Registration. 
 (a) On or prior to the Filing Deadline, and subject to the availability of Rule 415, the Company shall prepare and file
with the Commission a “Shelf” Registration Statement covering the resale of the Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415. The Registration Statement shall be on Form S-3 (except if the
Company is not then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in accordance herewith) and shall contain substantially the “Plan of
Distribution” attached hereto as Annex A, as modified by the Company as necessary to conform to comments from the Commission. Subject to the terms of this Agreement, the Company shall use its best efforts to cause the Registration
Statement to be declared effective under the Securities Act as promptly as possible after the filing thereof, and after the Effective Date, shall use its best efforts to keep such Registration Statement continuously effective under the Securities
Act until all Registrable Securities covered by such Registration Statement have been sold, subject, however, to any Allowable Grace Period. The Company agrees to request the Commission for acceleration of effectiveness at 4:00 p.m. Eastern Standard
Time on the Effective Date, and by 9:30 a.m. Eastern Standard Time on the Trading Day following the Effective Date, to file a final Prospectus with the Commission pursuant to Rule 424 and notify the Holders via facsimile of effectiveness of the
Registration Statement. 
 (b) If (i) the initial Registration Statement required to be filed by the Company pursuant to this Agreement
that covers all of the Registrable Securities is (A) not filed with the Commission on or before the Filing Deadline (if the Company files a Registration Statement without affording the Holders the opportunity to review and comment on the same
as required by Section 3(a) hereof, the Company shall not be deemed to have satisfied this clause) (a “Filing Failure”) or (B) not declared effective by the Commission on or before the Effectiveness Deadline (an
“Effectiveness Failure”) or (ii) on any day during the Effectiveness Period sales of all of the Registrable Securities cannot be made (other than during an Allowable 

  

 3 

 
Grace Period (as defined in Section 3(j)) pursuant to such Registration Statement (including, without limitation, because of a failure to keep such
Registration Statement effective, to disclose such information as is necessary for sales to be made pursuant to such Registration Statement, or to register all of the Registrable Securities) (a “Maintenance Failure”) then, as
partial relief for the damages to any Holder by reason of any such delay in or reduction of its ability to sell the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity), the
Company shall pay to each Holder of Registrable Securities an amount in cash equal to one percent (1%) of the aggregate Purchase Price that has actually been paid by such Holder in respect of its Registrable Securities on each of the following
dates: (i) the day of a Filing Failure; (ii) the day of an Effectiveness Failure; (iii) the initial day of a Maintenance Failure; (iv) on every thirtieth day after the day of a Filing Failure and thereafter (pro rated for periods
totaling less than thirty days) until such Filing Failure is cured; (v) on every thirtieth day after the day of an Effectiveness Failure and thereafter (pro rated for periods totaling less than thirty days) until such Effectiveness Failure is
cured, subject to adjustment as provided herein; and (vi) on every thirtieth day after the initial day of a Maintenance Failure and thereafter (pro rated for periods totaling less than thirty days) until such Maintenance Failure is cured. In
the event of a failure by the Company to cure an Effectiveness Failure on or before the thirtieth day after the date of the Effectiveness Deadline as set forth in clause (v) above, the Registration Delay Payment (as defined herein) for failure
to cure such an Effectiveness Failure after such initial 30-day cure period shall be increased to 1.5% per 30-day period thereafter; provided, however, that the Company shall not be liable to a Holder for any such payments in excess of 10% of
the aggregate Purchase Price that has actually been paid by such Holder in respect of its Registrable Securities. The payments to which a holder shall be entitled pursuant to this Section 2(b) are referred to herein as “Registration
Delay Payments.” Registration Delay Payments shall be paid on the earlier of (I) the dates set forth above and (II) the third Business Day after the event or failure giving rise to the Registration Delay Payments is cured. 

(c) In the event the number of shares available under a Registration Statement filed pursuant to Section 2(a) when declared effective or at any
time thereafter is insufficient to cover all of the Registrable Securities required to be covered by such Registration Statement, the Company shall amend the applicable Registration Statement, or file a new Registration Statement (on the short form
available therefor, if applicable), or both, so as to cover all of the Registrable Securities as of the Trading Day immediately preceding the date of the filing of such amendment or new Registration Statement, in each case, as soon as practicable,
but in any event not later than the later of: (i) sixty (60) days after the date substantially all of the Registrable Securities previously included in the initial Registration Statement have been sold; or (ii) the date that is six
(6) months after the Effective Date. The Company shall use its best efforts to cause such amendment and/or new Registration Statement to become effective as soon as practicable following the filing thereof. 
 (d) For the avoidance of doubt and notwithstanding anything contained herein to the contrary, no Registration Delay Payment is payable by the Company to
any particular Holder if any such Filing Failure, Effectiveness Failure, or Maintenance Failure, as the case may be, in relation to such Holder’s Registrable Securities included in such Registration Statement is caused by the default of the
obligations of the relevant Holder under this Agreement (including, without limitation, the obligations of the Holder as set forth in Section 3(a) below). In addition, notwithstanding anything contained herein to the contrary, in the event that
the Company is 

  

 4 

 
delinquent in filing the Registration Statement by a period of time such that the Effectiveness Deadline has passed and an Effectiveness Failure has
occurred, so that a Registration Delay Payment is triggered for both the Filing Failure and the Effectiveness Failure concurrently, then the Company shall only be obligated to pay one Registration Delay Payment for the concurrent failures, for
whichever failure results in a greater Registration Delay Payment. 
 3. Registration Procedures. 
 At such time as the Company is obligated to file a Registration Statement with the SEC pursuant to Section 2, the Company will use its best efforts
to effect the registration of the Registrable Securities in accordance with the intended method of distribution thereof and, pursuant thereto, the Company shall have the following obligations: 
 (a) The Company shall not file a Registration Statement, any Prospectus, or any amendments or supplements thereto in which the “Selling
Stockholder” section thereof differs from the disclosure received from a Holder in its Selling Shareholder Questionnaire (as amended and supplemented). Each Holder agrees to be named in the Registration Statement and to carry out the offer and
sale of Registrable Securities held by such Holder in a conformance with the Plan of Distribution attached hereto as Annex A, as modified by the Company as necessary to conform to comments from the Commission. Each Holder agrees to furnish to
the Company a completed Questionnaire in the form attached to this Agreement as Annex B (a “Selling Shareholder Questionnaire”) by the end of the eighth Trading Day following the date on which such Holder receives the Selling
Shareholder Questionnaire and draft materials in accordance with this Section. The Company shall ensure that each Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any
untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading,
except to the extent, but only to the extent, that (i) such untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder, its directors, authorized officers or
attorneys expressly for use therein, or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder its
directors, authorized officers or attorneys expressly for use in a Registration Statement, such Prospectus or such form of Prospectus or in any amendment or supplement thereto. Each Holder shall ensure that its Selling Shareholder Questionnaire
furnished to the Company shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein not misleading. 
 (b) Not less than five Trading Days prior to the filing of each Registration Statement and not less than two Trading Days prior to the filing of any
related amendment or supplement thereto, the Company shall permit the Holders to review and comment upon the Registration Statement and any amendments and supplements to all Registration Statements (except for Annual Reports on Form 10-K, Quarterly
Reports on Form 10-Q, Current Reports on Form 8-K and any similar or successor reports), and not file any Registration Statement or amendment or supplement thereto in a form to which the Holders or their legal counsel reasonably objects, provided
that the Holders or their legal counsel shall provide the Company 

  

 5 

 
with any comments within two (2) Trading Days of the receipt of the Registration Statement and shall provide the Company with any comments within one
(1) Trading Day of the receipt of any related amendment or supplement thereto. The Company shall furnish to the Holder, without charge, (i) copies of any correspondence from the Commission or the staff of the Commission to the Company or
its representatives relating to any Registration Statement, (ii) promptly after the same is prepared and filed with the Commission, one copy of any Registration Statement and any amendment(s) thereto, including financial statements and
schedules, all documents incorporated therein by reference, if requested by a Holder and not otherwise available on the EDGAR system, and all exhibits and (iii) upon the effectiveness of any Registration Statement, one copy of the prospectus
included in such Registration Statement and all amendments and supplements thereto. 
 (c) (i) Prepare and file with the Commission such
amendments, including post-effective amendments, to a Registration Statement and the Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable Securities for
the Effectiveness Period, except for periods based on events described in Section 3(d), (ii) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and as
so supplemented or amended to be filed pursuant to Rule 424; (iii) respond promptly to any comments received from the Commission with respect to a Registration Statement or any amendment thereto; and (iv) comply in all material respects
with the provisions of the Securities Act and the Exchange Act applicable to the Company with respect to the disposition of all Registrable Securities covered by a Registration Statement during the applicable period in accordance with the intended
methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented. 
 (d) Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (ii) through (iv) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have
been made) as promptly as reasonably possible, and in any event within one (1) Trading Day after the occurrence of the event requiring notice herein, (i) with respect to a Registration Statement or any post-effective amendment, when the
same has become effective; (ii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities;
(iii) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction; (iv) of the occurrence of any
event or passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated or deemed to be
incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it
will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading; or
(v) when the Commission notifies the Company whether there will be a review of such Registration Statement and whenever the Commission comments in writing on such Registration Statement (the Company shall provide true and complete copies
thereof and all written responses thereto to 

  

 6 

 
each of the Holders that pertain to the Holders as a Selling Stockholder or to the Plan of Distribution, but not information which the Company believes would
constitute material and non-public information). Any and all of such information contemplated by subparagraphs (i) through (v) shall remain confidential to each Holder until such information otherwise becomes public, unless disclosure by a
Holder is required by law. 
 (e) Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order
suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction, at the earliest practicable moment.

 (f) Furnish to each Holder whose Registrable Securities are included in any Registration Statement, without charge, if not otherwise
available on the EDGAR system (i) promptly after the same is prepared and filed with the Commission, at least one copy of such Registration Statement and any amendment(s) thereto, including financial statements and schedules, all documents
incorporated therein by reference, if requested by a Holder, all exhibits and each preliminary prospectus, (ii) upon the effectiveness of any Registration Statement, ten (10) copies of the prospectus included in such Registration Statement
and all amendments and supplements thereto (or such other number of copies as such Holder may reasonably request) and (iii) such other documents, including copies of any preliminary or final prospectus, as such Holder may reasonably request
from time to time in order to facilitate the disposition of the Registrable Securities owned by such Holder. 
 (g) Subject to the terms of
this Agreement, the Company hereby consents to the use of each Prospectus and each amendment or supplement thereto, provided by the Company pursuant to subpart (f) above, by each of the selling Holders in connection with the offering and sale
of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d). 
 (h) Prior to any resale of Registrable Securities by a Holder, register or qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the Registration or
qualification) of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification
(or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement;
provided, that the Company shall not be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not then so subject or file a
general consent to service of process in any such jurisdiction. 
 (i) Within two (2) Trading Days after a Registration Statement which
covers Registrable Securities is ordered effective by the Commission, deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the Holders whose Registrable Securities
are included in such Registration Statement) confirmation that such Registration Statement has been declared effective by the Commission. The Company shall cooperate with the Holders to facilitate the timely preparation and delivery 

  

 7 

 
of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free,
to the extent permitted by the Securities Act, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holders may reasonably request. 
 (j) Upon the occurrence of any event contemplated by this Section 3, as promptly as reasonably possible under the circumstances taking into account
the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare a supplement or amendment, including a post–effective amendment, to a Registration
Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither a Registration Statement nor such
Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. If
the Company notifies the Holders in accordance with clauses (ii) through (iv) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Company will use its best
efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration Statement and Prospectus,
provided that each period (each, a “Grace Period”) shall not exceed fifteen (15) consecutive days and during any three hundred sixty five (365) day period such Grace Periods shall not exceed an aggregate of thirty
(30) days and the first day of any Grace Period must be at least five (5) trading days after the last day of any prior Grace Period (each, an “Allowable Grace Period”). The Company shall notify the Holders in writing of
the date on which any Grace Period ends. For the purpose of determining the length of a Grace Period above, the Grace Period shall begin on and include the date the Holders receive the notice referred to above and shall end on the date the Holders
receive the notice referred to in the preceding sentence. 
 (k) Comply with all applicable rules and regulations of the Commission.

 (l) Prior to the effectiveness of the Registration Statement and all other amendments and supplements to the Prospectus, the Company may
require each selling Holder to furnish to the Company a certified statement as to (i) the number of shares of Common Stock beneficially owned by such Holder, (ii) the natural persons thereof that have voting and dispositive control over
the shares of Common Stock, and (iii) any affiliation between the Holder and either the Company’s independent registered public accountants or any member of FINRA, the Financial Industry Regulatory Authority (formerly NASD). 
 (m) The Company shall use its best efforts either to cause all of the Registrable Securities covered by a Registration Statement to be listed on the
primary securities exchange or stock market on which securities of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted under the rules of such exchange or stock
market. 
 (n) Neither the Company nor any Subsidiary or affiliate thereof shall identify any Holder as an underwriter in any public
disclosure or filing with the SEC or stock exchange 

  

 8 

 
or market and the fact that any Holder is deemed an underwriter by the SEC shall not relieve the Company of any obligations it has under this Agreement or
any other Transaction Document (as defined in the Purchase Agreement). 
 (o) If requested by a Holder, the Company shall as soon as
practicable (i) incorporate in a prospectus supplement or post-effective amendment such information as a Holder reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without
limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make
all required filings of such prospectus supplement or post-effective amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii) supplement or make amendments to any
Registration Statement if reasonably requested by a Holder holding any Registrable Securities. 
 4. Registration Expenses. All fees
and expenses incidental to the performance of or compliance with this Agreement by the Company shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to
in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses (A) with respect to filings required to be made with any securities exchange or stock
market on which the Common Stock is then listed for trading, and (B) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing), (ii) printing expenses incurred by the Company
(including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery expenses incurred by the Company, (iv) fees and disbursements of counsel for the Company,
(v) Securities Act liability insurance incurred by the Company, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions
contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all
salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as
required hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders. The Company shall
also reimburse the Holders for the fees and disbursements of one legal counsel for all Holders in connection with the registrations, filings, and qualifications made pursuant to this Agreement, which amount shall be limited to $20,000 for each
Registration Statement filed hereunder. 
 5. Indemnification. 
 (a) Indemnification by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder,
the officers, directors, agents, investment advisors, members, partners, and employees of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and
the officers, directors, members, shareholders, partners, and 

  

 9 

 
employees of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages,
liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of or relating to (1) any untrue statement of a material fact contained in a
Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, (2) any violation by the Company of the Securities Act,
Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or
omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder, its directors, authorized officers, or attorneys expressly for use therein, or to the extent that such information relates to such
Holder or such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder, its directors, authorized officers, or attorneys expressly for use in a Registration Statement,
such Prospectus or such form of Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose), (ii) in the case of an occurrence of an event of the type specified
in Section 3(d)(ii)-(iv), the use by such Holder of an outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice
contemplated in Section 7(c), or (iii) any such untrue statement, omission or violation is directly related to and primarily the result of a material breach of this Agreement or violation of law by Holder; or (3) any material breach
of this Agreement by the Company. 
 (b) Indemnification by Holders. Each Holder shall, severally and not jointly, indemnify and hold
harmless the Company, its directors, officers, agents, attorneys and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers,
agents, attorneys or employees of such controlling Persons, to the fullest extent permitted by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon any untrue or alleged untrue statement of a
material fact contained in any Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a
material fact required to be stated therein or necessary to make the statements therein not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information so furnished in writing by
such Holder, its directors, authorized officers, or attorneys to the Company specifically for inclusion in such Registration Statement or such Prospectus or (ii) to the extent that such information relates to such Holder’s proposed method
of distribution of Registrable Securities and was reviewed and expressly approved in writing by such Holder, its directors, authorized officers, or attorneys expressly for use in a Registration Statement (it being understood that the Holder has
approved Annex A hereto for this purpose), such Prospectus or such form of Prospectus or in any amendment or supplement thereto. In no event shall the liability of any selling Holder hereunder be greater in amount than the dollar amount of
the net proceeds received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation. 
  

 10 

 (c) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against
any Person entitled to indemnity hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying
Party shall have the right to assume the defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection with defense thereof; provided, that the
failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall have prejudiced the Indemnifying
Party. 
 An Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense
thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed in writing to pay such fees and expenses; (2) the Indemnifying Party shall have
failed promptly to assume the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding; or (3) the named parties to any such Proceeding (including any impleaded parties) include
both such Indemnified Party and the Indemnifying Party, and a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party, in which case, if such Indemnified Party notifies
the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than
one separate counsel shall be at the expense of the Indemnifying Party. The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or
delayed. 
 Subject to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party owing under this Section 5
(including reasonable fees and expenses to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified Party. 
 (d) Contribution. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an
Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and
Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by
reference to, among other things, whether any action in question, including any untrue statement of a material fact or omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or
Indemnified Party, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to
include, subject to the limitations set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or
expenses if the indemnification provided for in this Section was available to such party in accordance with its terms. 
  

 11 

 The parties hereto agree that it would not be just and equitable if contribution pursuant to this
Section 5(d) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding paragraph. Notwithstanding the provisions of this
Section 5(d), no Holder shall be required to contribute, in the aggregate, any amount in excess of the amount by which the proceeds actually received by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds
the amount of any damages that such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission, except in the case of fraud by such Holder. 
 The indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the
Indemnified Parties. 
 6. Reports Under the Exchange Act. 
 With a view to making available to the Holders the benefits of Rule 144 promulgated under the Securities Act or any other similar rule or regulation of
the Commission that may at any time permit the Holders to sell securities of the Company to the public without registration (“Rule 144”), the Company agrees to: 
 (a) make and keep public information available, as those terms are understood and defined in Rule 144; 
 (b) file with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act so
long as the Company remains subject to such requirements and the filing of such reports and other documents is required for the applicable provisions of Rule 144; and 
 (c) furnish to each Holder so long as such Holder owns Registrable Securities, promptly upon request, (i) a written statement by the Company, if true, that it has complied with the reporting requirements of Rule
144, the Securities Act and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably
requested to permit the Holders to sell such securities pursuant to Rule 144 without registration. 
 7. Miscellaneous. 
 (a) Other Registration Rights. Except for any registration statements filed or to be filed in respect of the holders of registration rights as set
forth in Schedule 4.3 of the Disclosure Schedules, the Company agrees and covenants that it will not register the shares of any other holder of its securities prior to registering the Shares. The Company and its security holders (other than the
Holders in such capacity pursuant hereto) designated by the Company may include securities of the Company in the Registration Statement in addition to the Registrable Securities; provided, however, Company agrees to limit the inclusion of, or
otherwise exclude, such securities in the Registration Statement to the extent necessary in order to satisfy its obligations pursuant to Section 2 above or to the extent necessary to register of all Registrable Securities as promptly as
possible. 
  

 12 

 (b) Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery
requirements of the Securities Act as applicable or an exemption therefrom to it in connection with sales of Registrable Securities pursuant to a Registration Statement. 
 (c) Discontinued Disposition. Each Holder agrees by its acquisition of Registrable Securities that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in
Section 3(d), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable
Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as possible. 
 (d) Amendments and Waivers. No provision of this Agreement may be amended or waived except in a written instrument signed by the Company and the
Holders holding not less than a majority of the Registrable Securities; provided, however, that if any amendment or waiver operates in a manner that treats any Holder differently from the other Holders, the consent of such Holder shall
also be required for such amendment or waiver. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. 
 (e) Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set
forth in the Purchase Agreement. 
 (f) Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the
successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. The Company may not assign its rights or obligations hereunder without the prior written consent of each Holder. The rights under this Agreement
shall be automatically assignable by any Holder to any transferee of such Holder’s Registrable Securities if: (i) such Holder agrees in writing with the transferee or assignee to assign such rights and a copy of such agreement is furnished
to the Company promptly after such assignment; (ii) the Company is, promptly after such transfer or assignment, furnished with written notice of (a) the name and address of such transferee or assignee; (b) the securities with respect
to which such registration rights are being transferred or assigned; and (c) the Company is provided with a Selling Shareholder Questionnaire executed by such transferee; (iii) immediately following such transfer or assignment the further
disposition of such securities by the transferee or assignee is restricted under the Securities Act and applicable state securities laws; (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of
this sentence the transferee or assignee agrees in writing with the Company to be bound by all of the provisions contained herein; and (v) such transfer shall have been made in accordance with the applicable requirements of the Purchase
Agreement. 
 (g) No Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor
shall the Company or any of its Subsidiaries, 

  

 13 

 
on or after the date of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted
to the Holders in this Agreement or otherwise conflicts with the provisions hereof. 
 (h) Execution and Counterparts. This Agreement
may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being
understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 
 (i) Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with, the
internal laws of the State of New York without regard to the choice of law principles thereof. Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the
United States District Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. Service of process in connection
with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. Each of the parties hereto irrevocably consents to the
jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts
and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT
TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER. 
 (j) Cumulative Remedies. The
remedies provided herein are cumulative and not exclusive of any other remedies provided by law. 
 (k) Severability. If any term,
provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that
contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of
such that may be hereafter declared invalid, illegal, void or unenforceable. 
  

 14 

 (l) Headings. The headings in this Agreement are for convenience only, do not constitute a part of
this Agreement, and shall not be deemed to limit or affect any of the provisions hereof. 
 (m) Independent Nature of Purchasers’
Obligations and Rights. The obligations of each Purchaser under this Agreement are several and not joint with the obligations of each other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any
other Purchaser under this Agreement. Nothing contained herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or
any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this Agreement or any other Transaction Document. Each
Purchaser acknowledges that no other Purchaser will be acting as agent of such Purchaser in enforcing its rights under this Agreement. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation the
rights arising out of this Agreement, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. 
 [Signature Page Follows] 
  

 15 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first
written above. 
  

			
	GEORESOURCES, INC.
		
	By:	 	  

		 	Frank A. Lodzinski
		 	President and Chief Executive Officer

  

 16 

 IN WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first
written above. 
  

			
	PURCHASER
	
	  

	Name of Purchaser
	
	  

	Signature of Purchaser or by Authorized Person executing for Purchaser

			
		
	 Printed Name:
	 	  

			
		
	 Title:
	 	  

			
		
	Its:	 	  

		 	(Printed Name of Authorized Person and Title for Person executing for Purchaser)

  

 17 

 ANNEX A 
 Plan of Distribution 
 The selling stockholders may, from time to time, sell any or all of their
shares of common stock on any stock exchange, market or trading facility on which the shares are traded or in private transactions. These sales may be at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined
at the time of sale, or at negotiated prices. The selling stockholders may use any one or more of the following methods when selling shares: 
  

	 	•	 	 ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers; 

  

	 	•	 	 block trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the
transaction; 

  

	 	•	 	 purchases by a broker-dealer as principal and resale by the broker-dealer for its account; 

  

	 	•	 	 an exchange distribution in accordance with the rules of the applicable exchange; 

  

	 	•	 	 privately negotiated transactions; 

  

	 	•	 	 short sales; 

  

	 	•	 	 broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share; 

  

	 	•	 	 a combination of any such methods of sale; and 

  

	 	•	 	 any other method permitted pursuant to applicable law. 

 The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus. 
 The selling stockholders may also engage in puts and calls and other transactions in our securities or derivatives of our securities and may sell or deliver shares in connection with these trades. 
 Broker-dealers engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from the purchaser) in amounts to be negotiated. The selling stockholders do not expect these commissions and discounts to exceed what is
customary in the types of transactions involved. Any profits on the resale of shares of common stock by a broker-dealer acting as principal might be deemed to be underwriting discounts or commissions under the Securities Act. Discounts, concessions,
commissions and similar selling expenses, if any, attributable to the sale of shares will be borne by a selling stockholder. The selling stockholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions
involving sales of the shares if 

  

 18 

 
liabilities are imposed on that person under the Securities Act. In connection with sales of the shares of common stock or otherwise, the selling
stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common stock in the course of hedging in positions they assume. The selling stockholders may also sell shares of common
stock short and deliver shares of common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The selling stockholders may also loan or pledge shares of common stock to
broker-dealers that in turn may sell such shares. 
 The selling stockholders may from time to time pledge or grant a security interest in
some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after
we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling
stockholders under this prospectus. 
 The selling stockholders also may transfer the shares of common stock in other circumstances, in which
case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus and may sell the shares of common stock from time to time under this prospectus after we have filed a supplement to
this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this
prospectus. 
 The selling stockholders and any broker-dealers or agents that are involved in selling the shares of common stock may be
deemed to be “underwriters” within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the shares of common stock
purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. 
 We are required to pay all fees and
expenses incident to the registration of the shares of common stock. We have agreed to indemnify the selling stockholders against certain claims, damages and liabilities, including liabilities under the Securities Act. 
 The selling stockholders have advised us that they have not entered into any agreements, understandings or arrangements with any underwriters or
broker-dealers regarding the sale of their shares of common stock, nor is there an underwriter or coordinating broker acting in connection with a proposed sale of shares of common stock by any selling stockholder. If we are notified by any selling
stockholder that any material arrangement has been entered into with a broker-dealer for the sale of shares of common stock, if required, we will file a supplement to this prospectus. If the selling stockholders use this prospectus for any sale of
the shares of common stock, they will be subject to the prospectus delivery requirements of the Securities Act. 
 Under the securities laws
of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered or qualified
for sale in such state or an exemption from registration or qualification is available and is complied with. 
  

 19 

 There can be no assurance that any selling stockholder will sell any or all of the shares of common stock
registered pursuant to the shelf registration statement, of which this prospectus forms a part. 
 The selling stockholders and any other
person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder, including, without limitation, Regulation M of the Exchange Act, which
may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any other participating person. Regulation M may also restrict the ability of any person engaged in the distribution of the shares of
common stock to engage in market-making activities with respect to the shares of common stock. All of the foregoing may affect the marketability of the shares of common stock and the ability of any person or entity to engage in market-making
activities with respect to the shares of common stock. 
 Once sold under the shelf registration statement, of which this prospectus forms a
part, the shares of common stock will be freely tradable in the hands of persons other than our affiliates. 
  

 20 

 ANNEX B 
 GeoResources, Inc. 
 Selling Securityholder Notice and Questionnaire 
 The undersigned beneficial owner of common stock, par value $0.01 per share (the “Common Stock”), of GeoResources, Inc., a Colorado
corporation (the “Company”), (the “Registrable Securities”) understands that the Company has filed or intends to file with the Securities and Exchange Commission (the “Commission”) a registration
statement on Form S-3 (the “Registration Statement”) for the registration and resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”), of the Registrable Securities, in accordance with
the terms of the Registration Rights Agreement, dated as of June __, 2008 (the “Registration Rights Agreement”), among the Company and the Holders named therein. A copy of the Registration Rights Agreement is available from the
Company upon request at the address set forth below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement. 
 Certain legal consequences arise from being named as a selling securityholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or not being named as a selling securityholder in the Registration Statement and the related
prospectus. 
 NOTICE 
 The undersigned beneficial owner (the “Selling Securityholder”) of Registrable Securities hereby elects to include the Registrable Securities owned by it and listed below in Item 3 (unless otherwise specified under
such Item 3) in the Registration Statement. 
  

 21 

 The undersigned hereby provides the following information to the Company and represents and warrants that
such information is accurate: 
 QUESTIONNAIRE 
  

					
	1.	  		  	Name.
			
		  	(a)	  	Full Legal Name of Selling Securityholder
			
		  		  	  

			
		  	(b)	  	Full Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below are held:
			
		  		  	  

			
		  	(c)	  	Full Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote or dispose of the securities covered by the
questionnaire):
			
		  		  	  

			
	2.	  		  	Address for Notices to Selling Securityholder:
			
		  		  	  

		  		  	  

		  		  	  

					
		
	 Telephone:
	  	  

					
	Fax:	  	  

					
	 Contact Person:
	  		  	  

					
			
	3.	  		  	Beneficial Ownership of Registrable Securities:
			
		  	(a)	  	Type and Number of Registrable Securities beneficially owned:
			
		  		  	  

			
		  		  	  

			
		  		  	  

  

 22 

					
	4.	  		  	Broker-Dealer Status:
			
		  	(a)	  	Are you a broker-dealer?
			
		  		  	 Yes   ̈                                   
     No   ̈

			
		  	(b)	  	If “yes” to Section 4(a), did you receive your Registrable Securities as compensation for investment banking services to the Company.
			
		  		  	 Yes   ̈                                   
     No   ̈

			
		  	Note:	  	If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.
			
		  	(c)	  	Are you an affiliate of a broker-dealer?
			
		  		  	 Yes   ̈                                   
     No   ̈

			
		  	(d)	  	If you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course of business, and at the time of the purchase of the Registrable
Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute the Registrable Securities?
			
		  		  	 Yes   ̈                                   
     No   ̈

			
		  	Note:	  	If no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.
			
	5.	  		  	Beneficial Ownership of Other Securities of the Company Owned by the Selling Securityholder.
		
		  	Except as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company other than the Registrable Securities
listed above in Item 3.
			
		  	(a)	  	Type and Amount of Other Securities beneficially owned by the Selling Securityholder:
			
		  		  	  

			
		  		  	  

			
	6.	  		  	Relationships with the Company:
		
		  	Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors or affiliates) during the past three years.

  

 23 

					
		  	State any exceptions here:
		
		  	  

		
		  	  

			
	7.	  		  	Relationships with the Company’s independent registered public accountant:
		
		  	Except as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities of the
undersigned) has held any position or office or has had any other material relationship with the Company’s independent registered public accountants, Grant Thornton LLP (or its predecessors or affiliates), during the past three
years.
		
		  	State any exceptions here:
		
		  	  

		
		  	  

 The undersigned agrees to promptly notify the Company of any inaccuracies or changes in the
information provided herein that may occur subsequent to the date hereof at any time while the Registration Statement remains effective. 
 By signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 7 and the inclusion of such information in the Registration Statement and the related prospectus and any
amendments or supplements thereto. The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and the related prospectus. 
  

 24 

 IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to
be executed and delivered either in person or by its duly authorized agent. 
  

					
	Dated:	 	Beneficial Owner:	 	  

					
		 	By:	 	  

		 	Name:	 	  

		 	Title:	 	  

 PLEASE FAX A COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE, AND RETURN THE ORIGINAL BY OVERNIGHT
MAIL, TO: 
 Reid Godbolt, Esq. 
 Jones & Keller

 1625 Broadway, 16th Floor 
 Denver, Colorado 80202 

Fax: (303) 573-0769 
  

 25Employment Agreement

 Exhibit 10.1 
 EXECUTION COPY 
 EMPLOYMENT AGREEMENT 
 (Thomas Stuart) 
 EMPLOYMENT AGREEMENT (the “Agreement”) dated
as of June 9, 2008 by and among PTS Holdings Corp. (“Holdings”), Catalent Pharma Solutions, Inc. (the “Operating Company,” and collectively with Holdings, the “Companies”) and Thomas Stuart (the
“Executive”). 
 WHEREAS, BHP PTS Holdings L.L.C. (formerly known as Phoenix Charter LLC), an affiliate of The Blackstone
Group (“Blackstone”), acquired the Pharmaceutical Technologies and Services segment of Cardinal Health, Inc., excluding the Martindale and Beckloff businesses, (the “PTS Businesses”); 
 WHEREAS, after consummation of the acquisition, the PTS Businesses merged with and into PTS Acquisition Corp. and became a subsidiary of Holdings;

 WHEREAS, the Companies desire to employ Executive and to enter into an agreement embodying the terms of such employment; and 

WHEREAS, Executive desires to accept such employment with the Companies and enter into such an agreement. 
 NOW THEREFORE, in consideration of the premises and mutual covenants herein and for other good and valuable consideration, the parties agree as follows:

 1. Term of Employment. Subject to the provisions of Section 7 of this Agreement, this Agreement and Executive’s
employment hereunder shall be effective as of August 1, 2007 (the “Effective Date”) and shall continue until the third anniversary of the Effective Date (the “Initial Term”). Subject to the provisions of
Section 7 of this Agreement, the Initial Term shall be extended as follows: this Agreement shall automatically renew for an additional one (1) year term commencing immediately following the last day of the Initial Term and each one
(1) year anniversary thereafter (each, a “Renewal Term”), unless, either of the Companies or Executive provides the other party written notice of non-renewal (the “Non-Renewal Notice”) at least sixty
(60) days’ prior to the end of the applicable term. The period during which Executive is employed by the Companies hereunder is hereinafter referred to as the “Employment Term”. This Agreement contains the entire
understanding between the parties hereto and supersedes the employment agreement, dated May 17, 1998, as amended on June 22, 2001 and August 10, 2006, between the Operating Company or any predecessor of Operating Company and Executive
(the “Prior Agreement”). 
 2. Position. 
 a. During the Employment Term, Executive shall serve as the President of Oral Technologies (a business segment of the Company). In such
position, Executive shall have such duties, authority and responsibilities as shall be determined from time 

 
to time by the Chief Executive Officer of the Operating Company (the “Chief Executive Officer”) and the Board of Directors of the Operating
Company (the “Board”) with respect to his responsibilities for the Operating Company, which duties, authority and responsibilities are customary for a President of a business segment of a similar size, type and nature to the
Companies. Executive shall report solely and directly to the Chief Executive Officer with respect to his responsibilities to the Operating Company. 
 b. During the Employment Term, Executive will devote Executive’s full business time and best efforts to the performance of his duties hereunder and will not engage in any other business, profession or occupation
for compensation or otherwise which would materially conflict or interfere with the rendition of such services either directly or indirectly, without the prior written consent of the Board; provided that nothing herein shall preclude
Executive from serving on the outside board of directors of one other company and, subject to the prior approval of the Board, which approval shall not be unreasonably withheld, from accepting appointment to or continuing to serve on such additional
boards of directors or trustees of any other business, corporation or charitable organization; provided that, in each case, such activities do not conflict or interfere with the performance of Executive’s duties hereunder or conflict with
Section 9. 
 3. Base Salary. During the Employment Term, commencing on September 3, 2007, the Operating Company shall pay
Executive an annual base salary at the annual rate of $424,000, payable in regular installments in accordance with the Operating Company’s usual payment practices. Executive shall be entitled to such increases, if any, in his base salary as may
be determined from time to time in the sole discretion of the Board, in accordance with the Operating Company’s normal annual review process for executives. Executive’s annual base salary, as in effect from time to time, is hereinafter
referred to as the “Base Salary”. 
 4. Annual Bonus. With respect to each full fiscal year during the Employment
Term, commencing with the 2008 fiscal year (which, for the avoidance of doubt, commenced July 1, 2007), Executive shall be eligible to earn an annual bonus award of 75% of his Base Salary, as in effect at the beginning of the applicable fiscal
year (the “Annual Bonus”), based upon the achievement of annual performance targets established by the Board, within the first three (3) months of each fiscal year during the Employment Term. The Annual Bonus, if any, shall be
paid to Executive within two and one-half (2-1/2) months after the end of the applicable fiscal year. 
 5. Employee Benefits;
Perquisites; Fringe Benefits. 
 a. During the Employment Term, Executive shall be entitled to participate in the
Operating Company’s group health, life, disability and other employee benefit plans as in effect from time to time (collectively “Employee Benefits”), on a basis which is no less favorable than is provided to other executives
of the Operating Company, to the extent consistent with applicable law and the terms of the applicable plans and to standard perquisites. 
 b. During the Employment Term, the Operating Company shall pay to Executive a car allowance in a gross amount of $22,284 during each fiscal year, payable bi-weekly. 
  

 2 

 c. Executive shall be entitled, during the Employment Term, to vacations and fringe
benefits consistent with the practices of the Operating Company. 
 6. Business Expenses. During the Employment Term, reasonable
business expenses incurred by Executive in the performance of Executive’s duties hereunder shall be reimbursed by the Operating Company in accordance with the Operating Company’s policies. 
 7. Termination. The Employment Term and Executive’s employment hereunder may be terminated by either of the Companies or Executive at any
time and for any reason; provided that, unless otherwise provided herein, either party will be required to give the other party at least sixty (60) days’ advance written notice of any termination of Executive’s employment.
Notwithstanding any other provision of this Agreement, the provisions of this Section 7 shall govern Executive’s rights under this Agreement upon termination of employment with the Companies and their affiliates. 
 a. By the Companies For Cause or By Executive Due to Voluntary Resignation Without Good Reason. 
 (i) The Employment Term and Executive’s employment hereunder may be terminated by either of the Companies for Cause (as defined
below), which termination shall be effective immediately, or by Executive by his voluntary resignation without Good Reason (as defined below). 
 (ii) If Executive’s employment is terminated by either of the Companies for Cause, or if Executive resigns without Good Reason, Executive shall be entitled to receive: 
 (A) accrued, but unpaid Base Salary, earned through the date of termination; 
 (B) accrued, but unpaid Annual Bonus, earned for any previously completed fiscal year, paid in accordance with Section 4 (except to
the extent payment is otherwise deferred pursuant to any applicable deferred compensation arrangement with the Companies); 
 (C) reimbursement, within forty-five (45) days following submission by Executive to the Companies, as applicable, of appropriate supporting documentation, for any unreimbursed business expenses properly incurred by Executive in
accordance with the Operating Company’s policies prior to the date of Executive’s termination; provided claims for such reimbursement (accompanied by appropriate supporting documentation) are submitted to the Operating Company within
ninety (90) days following the date of Executive’s termination of employment; and 
 (D) such Employee Benefits, if
any, as to which Executive may be entitled under the employee benefit plans of the Operating Company (the amounts described in clauses (A) through (D) hereof being referred to as the “Accrued Rights”). 
  

 3 

 Following such termination of Executive’s employment by either of the Companies for Cause or voluntary resignation
by Executive without Good Reason, except as set forth in this Section 7(a)(ii) and Section 11, Executive shall have no further rights to any compensation or any other benefits under this Agreement. 
 (iii) For purposes of this Agreement, the terms: 
 (A) “Cause” shall mean (I) Executive’s willful failure to perform his duties, which failure is not cured
within fifteen (15) days following written notice, (II) Executive’s conviction or confessing to or becoming subject to proceedings that provide a reasonable basis for either of the Companies to believe that Executive has engaged in a
(x) felony, (y) crime involving dishonesty, or (z) crime involving moral turpitude and which is demonstrably injurious to the Companies and their subsidiaries, (III) Executive’s willful malfeasance or misconduct which is
demonstrably injurious to the Companies and their subsidiaries, or (IV) breach by Executive of the material terms of this Agreement including, without limitation, Sections 8 and 9 of this Agreement. For purposes of this definition, no act or failure
to act by Executive shall be deemed “willful” unless effected by Executive not in good faith. 
 (B) “Good
Reason” shall mean, without Executive’s consent, (I) a substantial diminution in Executive’s position or duties, or assignment of duties materially inconsistent with his position as specified hereunder, (II) any reduction in
Executive’s Base Salary, (III) failure of the Companies to pay compensation or benefits when due under this Agreement, (IV) the relocation of the Companies’ headquarters to a location more than fifty (50) miles from its location on
the Effective Date, (V) the failure of any successor to all or substantially all of the assets of the Operating Company to assume and agree to honor this Agreement, unless assumption of the Agreement occurs by operation of law, or (VI) the
failure to provide an annual bonus opportunity that is at least at the same level as established for the 2008 fiscal year (which, for the avoidance of doubt, commenced July 1, 2007), in each case, which is not cured within thirty (30) days
following either of the Companies’ receipt of written notice from Executive describing the event constituting Good Reason; which notice shall be provided to either of the Companies within ninety (90) days following Executive’s
knowledge of the occurrence of the event constituting Good Reason. 
 b. Disability or Death. 
 (i) The Employment Term and Executive’s employment hereunder shall terminate upon Executive’s death and may be terminated by
either of the Companies if Executive becomes physically or mentally incapacitated and is therefore unable for a period of six (6) consecutive months or for an aggregate of nine (9) months in any twenty-four (24) consecutive month
period to perform Executive’s duties (such incapacity is hereinafter referred to as “Disability”). Any question as to the existence of the Disability of Executive as to which Executive and either of the Companies cannot agree
shall be determined in writing by a qualified independent physician mutually acceptable to Executive and either of the Companies. If Executive and the Companies cannot agree as to a qualified independent physician, each shall appoint a physician and
those two physicians shall select a third who shall make such 

  

 4 

 
determination in writing. The determination of Disability made in writing to either of the Companies and Executive shall be final and conclusive for all
purposes of the Agreement. 
 (ii) Upon termination of Executive’s employment hereunder for Disability, Executive shall
be entitled to receive: 
 (A) the Accrued Rights; and 
 (B) provided Executive (x) does not violate the restrictions set forth in Sections 8 and 9 of this Agreement and (y) executes,
delivers and does not revoke a general release of claims against the Companies and their affiliates, in the form attached hereto as Exhibit A, payment of an amount equal to two (2) times Executive’s Base Salary, payable in equal
monthly installments over a two-year period following the date of termination of employment (such two-year period, the “Severance Period”), consistent with the Operating Company’s past payroll practices; provided, however, the
amount payable under this Section 7(b)(ii)(B) shall be reduced by any amounts paid or payable to Executive under the Companies’ or any subsidiary’s disability plan. 
 Following Executive’s termination of employment due to Disability, except as set forth in this Section 7(b)(ii) and Section 11, Executive shall have no further rights to any compensation or any other
benefits under this Agreement. 
 (iii) Upon termination of Executive’s employment hereunder for death, Executive or
Executive’s estate (as the case may be) shall be entitled to receive the Accrued Rights. Following Executive’s termination of employment due to death, except as set forth in this Section 7(b)(iii) and Section 11, Executive shall
have no further rights to any compensation or any other benefits under this Agreement. 
 c. By the Companies Without
Cause; Resignation by Executive for Good Reason. 
 (i) The Employment Term and Executive’s employment hereunder may
be terminated by either of the Companies without Cause (other than by reason of death or Disability) or by Executive’s resignation for Good Reason. 
 (ii) If Executive’s employment is terminated by either of the Companies without Cause (other than by reason of death or Disability) or if Executive resigns for Good Reason, Executive shall be entitled to receive:

 (A) the Accrued Rights; 
 (B) a pro-rata portion of the Annual Bonus, if any, that Executive would have been entitled to receive pursuant to Section 4 hereof for the fiscal year of termination, multiplied by a fraction, the numerator of
which is the number of days during which Executive was employed by the Companies in the fiscal year of Executive’s termination, and the denominator of which is 365 (the “Pro-Rata Bonus”), with such Pro-Rata Bonus payable to
Executive pursuant to Section 4 had Executive’s employment not terminated; 
  

 5 

 (C) provided Executive (x) does not violate the restrictions set forth in Sections
8 and 9 of this Agreement and (y) executes, delivers and does not revoke a general release of claims against the Companies and their affiliates, in the form attached hereto as Exhibit A, payment of an amount equal to two (2) times
the sum of (1) Executive’s Base Salary and (2) the annual bonus award of 75% of Base Salary (for the avoidance of doubt, regardless of whether any applicable annual performance targets are attained), payable in equal monthly
installments over the Severance Period, consistent with the Operating Company’s past payroll practices; 
 (D) Executive
and his spouse and eligible dependents (to the extent covered immediately prior to such termination) shall continue to be eligible to participate in all of the Operating Company’s group health plans for which Executive was eligible immediately
prior to the date of his termination (or to the extent such coverage is not permissible under the terms of such plan(s), comparable coverage) for the Severance Period or, if sooner, until Executive is covered under the group health plans of any
other employer (or comparable coverage to the extent applicable); provided, however, that if such coverage is longer than eighteen (18) months, the Operating Company shall pay Executive, on the first business day of each month, an
amount (on a tax-grossed up basis) equal to the premium subsidy the Operating Company would have otherwise paid on Executive’s behalf for such coverage during the balance of the Severance Period. This coverage for which Executive and his spouse
and eligible dependents shall continue to be eligible under this clause shall be made available to Executive on the same terms and conditions as are offered to continuing executives. The COBRA health care continuation coverage period under
Section 4980B of the Internal Revenue Code of 1986, as amended, (the “Code”), or any replacement or successor provision of United States tax law, shall run concurrently with the Severance Period; and 
 (E) provide Executive with benefits in accordance with Section 5(b) during the Severance Period. 
 Following Executive’s termination of employment by either of the Companies without Cause (other than by reason of Executive’s death or Disability) or by
Executive’s resignation for Good Reason, except as set forth in this Section 7(c)(ii) and Section 11, Executive shall have no further rights to any compensation or any other benefits under this Agreement. 
 d. Non-Renewal of Employment Term. 
 (i) In the event Executive provides either of the Companies with the Non-Renewal Notice pursuant to Section 1, unless Executive’s employment is earlier terminated pursuant to paragraphs (a), (b) or
(c) of this Section 7, the expiration of the Employment Term and Executive’s termination of employment hereunder (whether or not Executive continues as an employee of either of the Companies thereafter) shall be deemed to occur on the
close of business on the day immediately preceding the Renewal Term, and Executive shall be entitled to receive the Accrued Rights. 
 Following such termination of Executive’s employment under this Section 7(d)(i), except as set forth in this Section 7(d)(i) and Section 11, Executive shall have no further rights to any compensation or any other
benefits under this Agreement. 
  

 6 

 (ii) In the event either of the Companies provides Executive with the Non-Renewal Notice
pursuant to Section 1, unless Executive’s employment is earlier terminated pursuant to paragraphs (a), (b) or (c) of this Section 7, the expiration of the Employment Term and Executive’s termination of employment
hereunder (whether or not Executive continues as an employee of either of the Companies thereafter) shall be deemed to occur on the close of business on the day immediately preceding the Renewal Term, and Executive shall be entitled to receive the
Accrued Rights. 
 In addition to the Accrued Rights, as a result of such termination of employment, Executive shall be entitled to receive:

 (A) the Pro Rata Bonus, with such Pro-Rata Bonus payable to Executive pursuant to Section 4 had Executive’s
employment not terminated; 
 (B) provided Executive (x) does not violate the restrictions set forth in Sections 8 and 9
of this Agreement and (y) executes, delivers and does not-revoke a general release of claims against the Companies and their affiliates, in the form attached hereto as Exhibit A, payment of an amount equal to two (2) times the sum
of (1) Executive’s Base Salary and (2) the annual bonus award of 75% of Base Salary (for the avoidance of doubt, regardless of whether any applicable annual performance targets are attained), payable in equal monthly installments over
the Severance Period, consistent with the Operating Company’s past payroll practices; 
 (C) Executive and his spouse
and eligible dependents (to the extent covered immediately prior to such termination) shall continue to be eligible to participate in all of the Operating Company’s group health plans for which Executive was eligible immediately prior to the
date of his termination (or to the extent such coverage is not permissible under the terms of such plan(s), comparable coverage) for the Severance Period or, if sooner, until Executive is covered under the group health plans of any other employer
(or comparable coverage to the extent applicable); provided, however, that if such coverage is longer than eighteen (18) months, the Operating Company shall pay Executive, on the first business day of each month, an amount (on a
tax-grossed up basis) equal to the premium subsidy the Operating Company would have otherwise paid on Executive’s behalf for such coverage during the balance of the Severance Period. This coverage for which Executive and his spouse and eligible
dependents shall continue to be eligible under this clause shall be made available to Executive on the same terms and conditions as are offered to continuing executives. The COBRA health care continuation coverage period under Section 4980B of
the Code, or any replacement or successor provision of United States tax law, shall run concurrently with the Severance Period; and 
 (D) provide Executive with benefits in accordance with Section 5(b) during the Severance Period. 
 Following such termination
of Executive’s employment under this Section 7(d)(ii), except as set forth in this Section 7(d)(ii) and Section 11, Executive shall have no further rights to any compensation or any other benefits under this Agreement.

 (iii) Unless the parties otherwise agree in writing, continuation of Executive’s employment with the Companies beyond
the expiration of the Employment Term shall be deemed an employment at-will and shall not be deemed to extend any of the provisions of this Agreement and Executive’s employment may thereafter be terminated at will by either Executive or either
of the Companies; provided that the provisions of Sections 8, 9 and 10 of this Agreement shall survive any termination of this Agreement or Executive’s termination of employment hereunder. 
  

 7 

 e. Notice of Termination. Any purported termination of employment by the Companies
or by Executive (other than due to Executive’s death) shall be communicated by written Notice of Termination to the other party hereto in accordance with Section 12(i) hereof. For purposes of this Agreement, a “Notice of
Termination” shall mean a notice which shall indicate the specific termination provision in this Agreement relied upon and shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of
employment under the provision so indicated. 
 8. Non-Competition. 
 a. Executive acknowledges and recognizes the highly competitive nature of the businesses of the Companies and their subsidiaries and
accordingly agrees as follows: 
 (1) During the Employment Term and for a period of one year following the date Executive
ceases to be employed by the Companies under this Agreement for any reason (the “Restricted Period”), Executive will not, whether on Executive’s own behalf or on behalf of or in conjunction with any person, firm, partnership,
joint venture, association, corporation or other business organization, entity or enterprise whatsoever (“Person”), directly or indirectly solicit or assist in soliciting in competition with the Companies and their subsidiaries, the
business of any client or prospective client: 
  

	 	(i)	with whom Executive had personal contact or dealings on behalf of the Companies or any of their subsidiaries during the one year period preceding Executive’s termination of
employment; 

  

	 	(ii)	with whom employees reporting to Executive have had personal contact or dealings on behalf of the Companies or any of their subsidiaries during the one year immediately preceding
Executive’s termination of employment; or 

  

	 	(iii)	for whom Executive had direct or indirect responsibility during the one year immediately preceding Executive’s termination of employment. 

 (2) During the Restricted Period, Executive will not directly or indirectly: 
  

	 	(i)	 engage in any business that competes with the business of the Companies or any of their subsidiaries, including, contract services 

  

 8 

	 	 
to pharmaceutical, biotechnology and vitamin/mineral supplements manufacturers related to formulation, analysis manufacturing and packaging and any other
product or service of the type developed, manufactured or sold by the Companies or any of their subsidiaries (including, without limitation, any other business that the Companies or any of their subsidiaries is taking or has taken specific actions
in furtherance of engaging in, which actions (taken together) would lead a reasonable person to conclude, as of the date of Executive’s termination of employment, that it was more likely than not that the Companies or any of their subsidiaries
intended to pursue engaging in such business (so long as Executive knew or reasonably should have known about such actions prior to the date of Executive’s termination of employment)) in any geographical area where the Companies or any of their
subsidiaries conduct business (a “Competitive Business”) (Exhibit B hereto contains examples of those business that are not deemed to be a Competitive Business); 

  

	 	(ii)	enter the employ of, or render any services to, any Person (or any division or controlled or controlling affiliate of any Person) who or which engages in a Competitive Business;

  

	 	(iii)	acquire a financial interest in, or otherwise become actively involved with, any Competitive Business, directly or indirectly, as an individual, partner, shareholder, officer,
director, principal, agent, trustee or consultant; or 

  

	 	(iv)	interfere with, or attempt to interfere with, business relationships (whether formed before, on or after the date of this Agreement) between either of the Companies or any of their
subsidiaries and customers, clients, suppliers, partners, members or investors of either of the Companies or such subsidiaries. 

 (3) Notwithstanding anything to the contrary in this Agreement, (i) Executive may, directly or indirectly, own, solely as an investment, securities of any Person engaged in the business of the Companies or any of their subsidiaries
which are publicly traded on a national or regional stock exchange or on the over-the-counter market if Executive (x) is not a controlling person of, or a member of a group which controls, such person and (y) does not, directly or
indirectly, own 5% or more of any class of securities of such Person and (ii) Executive may, directly or indirectly, through any other entity, be employed by, engaged as a consultant to or perform any other services for or on behalf of any
Person, directly or indirectly, engaged in a business that, as part of its overall business has a Competitive Business, provided that Executive is not employed by or is not directly or indirectly involved with the operation or management of that
Competitive Business. 
  

 9 

 (4) During the Restricted Period, Executive will not, whether on Executive’s own behalf or on behalf
of or in conjunction with any Person, directly or indirectly: 
  

	 	(i)	solicit or encourage any employee of the Companies or any of their subsidiaries to leave the employment of the Companies or any of their subsidiaries; or 

 

	 	(ii)	hire any such employee who was employed by the Companies or any of their subsidiaries as of the date of Executive’s termination of employment with the Companies or who left the
employment of the Companies or any of their subsidiaries coincident with, or within six months prior to or after, the termination of Executive’s employment with the Company; provided, however, that this restriction shall cease to apply to any
employee who has not been employed by the Companies or any of their subsidiaries for at least six months. 

 (5) During the
Restricted Period, Executive will not, directly or indirectly, solicit or encourage to cease to work with the Companies or any of their subsidiaries any consultant then under contract with the Companies or any of their subsidiaries. 
 b. It is expressly understood and agreed that although Executive and the Companies consider the restrictions contained in this
Section 8 to be reasonable, if a final judicial determination is made by a court of competent jurisdiction that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction against Executive, the
provisions of this Agreement shall not be rendered void but shall be deemed amended to apply as to such maximum time and territory and to such maximum extent as such court may judicially determine or indicate to be enforceable. Alternatively, if any
court of competent jurisdiction finds that any restriction contained in this Agreement is unenforceable, and such restriction cannot be amended so as to make it enforceable, such finding shall not affect the enforceability of any of the other
restrictions contained herein. 
 The provisions of this Section 8 shall survive the termination of Executive’s employment for any reason.

 9. Confidentiality; Removal of Property. 
 a. Confidentiality. 
 (i) For purposes of this Agreement, “proprietary information” shall mean any information relating to the business of the Companies or any of their subsidiaries that has not previously been publicly released
by duly authorized representatives of the Companies and shall include (but shall not be limited to) Companies’ information encompassed in all research, product development, designs, plans, formulations and formulating techniques, proposals,
marketing and sales plans, financial information, costs, pricing information, strategic business plans, customer information, and all methods, concepts, or ideas in or reasonably related to the business of the Companies. 
  

 10 

 (ii) The Executive agrees to regard and preserve as confidential all proprietary
information pertaining to the Companies’ business that has been or may be obtained by the Executive in the course of his employment with the Companies, whether he has such information in his memory or in writing or other physical form. The
Executive will not, without prior written authority from the Companies to do so, use for his benefit or purposes, or disclose to any other person, firm, partnership, corporation or other entity, either during the term of his employment hereunder or
thereafter, any proprietary information connected with the business or developments of the Companies, except as required in connection with the performance by the Executive of his duties and responsibilities as an employee of the Companies. This
provision shall not apply after the proprietary information has been voluntarily disclosed to the public, independently developed and disclosed by others, or otherwise enters the public domain through lawful means. 
 b. Removal of Documents or Objects. The Executive agrees not to remove from the premises of the Companies, except as an employee of
the Companies in pursuit of the business of the Companies or any of its subsidiaries, or except as specifically permitted in writing by the Companies, any document (regardless of the medium on which it is recorded), object, computer program,
computer source code, object code or data (the “Documents”) containing or reflecting any proprietary information of the Companies. The Executive recognizes that all such Documents, whether developed by him or by someone else, are
the exclusive property of the Companies. 
 c. The provisions of this Section 9 shall survive the termination of
Executive’s employment for any reason. 
 10. Specific Performance. Executive acknowledges and agrees that the Companies’
remedies at law for a breach or threatened breach of any of the provisions of Section 8 or Section 9 would be inadequate and the Companies would suffer irreparable damages as a result of such breach or threatened breach. In recognition of
this fact, Executive agrees that, in the event of such a breach, in addition to any remedies at law, the Companies, without posting any bond, shall be entitled to cease making any payments or providing any benefit otherwise required by this
Agreement and obtain equitable relief in the form of specific performance, temporary restraining order, temporary or permanent injunction or any other equitable remedy which may then be available. 
 11. Indemnification. 
 a. The Companies shall indemnify Executive, to the fullest extent permitted by applicable law, against all reasonable costs, charges and expenses incurred or sustained by Executive, including the advancement of the cost and expenses of
legal counsel, in connection with any action, suit or proceeding to which Executive may be made a party by reason of Executive being or having been an officer, director, or employee of the Companies or any of their respective subsidiaries or
affiliates. 
 b. Executive shall be covered, during the entire term of this Agreement and thereafter for as long as a claim
may be brought against Executive, by officer and director liability insurance in amounts and on terms similar to that afforded to other executives and/or directors of the Companies, or their affiliates, which such insurance shall be paid by the
Operating Company. 
  

 11 

 12. Miscellaneous. 
 a. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New Jersey, without
regard to conflicts of laws principles thereof. 
 b. Entire Agreement/Amendments. This Agreement contains the entire
understanding of the parties with respect to the employment of Executive by the Companies. There are no restrictions, agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other
than those expressly set forth herein. This Agreement may not be altered, modified, or amended except by written instrument signed by the parties hereto. 
 c. No Waiver. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver of such party’s rights or deprive such party of the right
thereafter to insist upon strict adherence to that term or any other term of this Agreement. 
 d. Severability. In
the event that any one or more of the provisions of this Agreement shall be or become invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions of this Agreement shall not be affected
thereby. 
 e. Assignment. This Agreement, and all of Executive’s rights and duties hereunder, shall not be
assignable or delegable by Executive. Any purported assignment or delegation by Executive in violation of the foregoing shall be null and void ab initio and of no force and effect. This Agreement may be assigned by the Companies to a person
or entity which is an affiliate or a successor in interest to substantially all of the business operations of the Companies. Upon such assignment, the rights and obligations of the Companies hereunder shall become the rights and obligations of such
affiliate or successor person or entity. 
 f. Set Off; Mitigation. The Operating Company’s obligation to pay
Executive the amounts provided and to make the arrangements provided hereunder shall be subject to setoff, counterclaim or recoupment of amounts owed by Executive to the Companies or their affiliates. Executive shall not be required to mitigate the
amount of any payment provided for pursuant to this Agreement by seeking other employment. The Operating Company’s obligation to make the payments and provide the benefits required under Section 7 hereof shall not be reduced or otherwise
affected by any compensation or benefits paid or provided to Executive as a result of any other employment (except to the extent otherwise provided in Section 7(c)(ii)(D) or Section 7(d)(ii)(C) with respect to the time when the
Companies’ obligation to provide continued group health coverage ceases). 
 g. Compliance with Section 409A of
the Code. Notwithstanding anything herein to the contrary, if, at the time of Executive’s termination of employment with the Companies, the Companies have securities which are publicly traded on an established securities market and
Executive is a “specified employee” (as defined in Section 409A of the Code) and the deferral of the commencement of any payments or benefits otherwise payable pursuant to 

  

 12 

 
Section 7 as a result of such termination of employment is necessary in order to prevent any accelerated or additional tax under Section 409A of
the Code, then, to the extent permitted by Section 409A of the Code, the Operating Company will defer the commencement of the payment of any such payments or benefits hereunder (without any reduction in such payments or benefits ultimately paid
or provided to Executive) that are in excess of the lesser of (i) two (2) times Executive’s then annual compensation or (ii) two (2) times the limit on compensation then set forth in Section 401(a)(17) of the Code,
until the date that is six months following Executive’s termination of employment with the Companies (or the earliest date as is permitted under Section 409A of the Code). If any payments or benefits are deferred due to such requirements,
such amounts will be paid in a lump sum to Executive at the end of such six (6) month period. The Companies shall consult with Executive in good faith regarding the implementation of the provisions of this Section 12(g). 
 h. Successors; Binding Agreement. This Agreement shall inure to the benefit of and be binding upon personal or legal
representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. 
 i. Notice. For
the purpose of this Agreement, notices and all other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered by hand or overnight courier or three days after it has been mailed by
United States registered mail, return receipt requested, postage prepaid, addressed to the respective addresses set forth below in this Agreement, or to such other address as either party may have furnished to the other in writing in accordance
herewith, except that notice of change of address shall be effective only upon receipt. 
 If to Holdings: 
 14 Schoolhouse Road 
 Somerset, NJ 08873 
 Attention: Secretary 
 with a required copy to: 
 The Blackstone Group 
 345 Park Avenue 
 New York, New York 10154 
 Attention: Chinh Chu 
 If to the Operating Company: 
 14 Schoolhouse Road 
 Somerset, NJ 08873 
 Attention: Secretary 
 If to Executive: 
  

 13 

 To the most recent address of Executive set forth in the personnel records of the
Company, 
 j. Executive Representation. Executive hereby represents to the Companies that the execution and delivery
of this Agreement by Executive and the performance by Executive of Executive’s duties hereunder shall not constitute a breach of, or otherwise contravene, the terms of any employment agreement, separation agreement or other agreement or policy
to which Executive is a party or otherwise bound. 
 k. Prior Agreements. This Agreement supercedes all prior
agreements and understandings (including verbal agreements) between Executive and the Companies and/or their affiliates regarding the terms and conditions of Executive’s employment with the Companies and/or their affiliates. 
 l. Further Assurances. The parties shall, with reasonable diligence, do all things and provide all reasonable assurances as may be
required to complete the transactions contemplated by this Agreement, and each party shall provide such further documents or instruments required by any other party as may be reasonably necessary or desirable to give effect to this Agreement and
carry out its provisions. 
 m. Cooperation. Executive shall provide Executive’s reasonable cooperation in
connection with any action or proceeding (or any appeal from any action or proceeding) which relates to events occurring during Executive’s employment hereunder, and the Companies will reimburse Executive for all expenses reasonably incurred in
providing such cooperation. This provision shall survive any termination of this Agreement. The Companies shall also reimburse Executive for any lost wages incurred in connection with any cooperation provided under this Section 12(m) after
Executive’s termination date. 
 n. Withholding Taxes. The Companies may withhold from any amounts payable under
this Agreement such Federal, state and local taxes as may be required to be withheld pursuant to any applicable law or regulation. 
 o. Counterparts. This Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument. 
 [Rest of Page Intentionally Left Blank] 
  

 14 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as of the day and year first
above written. 
  

									
	PTS HOLDINGS CORP.	 		 	THOMAS STUART
			
	/s/ John Lowry	 		 	/s/ Thomas Stuart
	By:	 	John Lowry	 		 		 	
	Title: 	 	President and Chief Executive Officer	 		 		 	
				
	CATALENT PHARMA SOLUTIONS, INC.	 		 		 	
				
	/s/ John Lowry	 		 		 	
	By:	 	John Lowry	 		 		 	
	Title: 	 	President and Chief Executive Officer	 		 		 	

  

 15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00143-of-00352.parquet"}]]